Investment
Features
FeesSafety
Academy
More
Pluang+

Rheinmetall cuts 2026 guidance by €300M after German warship order cancellation despite strong H1 growth

Market News
06 Aug 2026
CNBC
View Source
Bearish
Rheinmetall cuts 2026 guidance by €300M after German warship order cancellation despite strong H1 growth

Rheinmetall lowered its 2026 revenue forecast by 300 million euros following the cancellation of a major German government warship order. Despite this setback, the defense company reported a 39% increase in sales and a 74% rise in profits in the first half of 2024, driven by strong demand for military vehicles, ammunition, and air-defense systems. The company recently expanded into naval vessels with a new acquisition but faces investor concerns about its ability to meet growing order demands amid industry delays. The guidance cut highlights the risks of government contract changes despite overall strong growth in the European defense sector since Russia's invasion of Ukraine.

More News

Equitable Holdings directors sell shares amid mixed institutional holdings changes

Equitable Holdings directors sell shares amid mixed institutional holdings changes

Two directors of Equitable Holdings sold shares recently, with Bertram L. Scott selling 2,780 shares and Craig C. MacKay selling 2,000 shares. Meanwhile, institutional investors showed mixed activity: Engineers Gate Manager LP drastically cut its hol...

Market News
Neutral
47 minutes ago
Greenland mining and chip ETFs soar on new security deal and AI optimism

Greenland mining and chip ETFs soar on new security deal and AI optimism

Shares of Greenland-linked mining companies surged following a new U.S.-Denmark-Greenland security agreement that boosted investor interest in Greenland's mineral resources. Greenland Mines Ltd. jumped over 229%, while Critical Metals Corp. rose near...

Market News
Bullish
47 minutes ago
Biotech stocks and leveraged ETFs lead market declines amid volatile trading and clinical news.

Biotech stocks and leveraged ETFs lead market declines amid volatile trading and clinical news.

Biotech stocks and leveraged ETFs were the biggest losers in the market, with Cue Biopharma dropping 23.7% despite positive Phase 2 clinical results. Leveraged ETFs tied to AMD, Strategy, and Novo Nordisk also saw sharp declines due to their daily-re...

Market News
Bearish
47 minutes ago
Priority Technology to go private in $1.6B deal led by CEO, stock downgraded to Hold amid fair value probe.

Priority Technology to go private in $1.6B deal led by CEO, stock downgraded to Hold amid fair value probe.

Priority Technology Holdings is being taken private in a $1.6 billion deal led by its Chairman and CEO, Thomas Priore. The acquisition price is $8.05 per share, matching the analyst price target set by Lake Street, which downgraded the stock to 'Hold...

Company Fundamentals
Neutral
1 hour ago
General Mills Q3 2026 EPS expected to drop 16.3% amid lower revenue forecast

General Mills Q3 2026 EPS expected to drop 16.3% amid lower revenue forecast

General Mills is set to report its Q3 2026 earnings with an expected 16.3% decline in earnings per share to $0.72 and revenue forecast around $4.35 billion, down from last year. Despite these declines, the company reaffirmed its full-year adjusted EP...

Company Fundamentals
Bearish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App